1. Home
  2. NAUT

as of 02-13-2026 3:36pm EST

$2.20
+$0.07
+3.29%
Stocks Industrials Biotechnology: Laboratory Analytical Instruments Nasdaq

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

Founded: 2016 Country:
United States
United States
Employees: N/A City: SEATTLE
Market Cap: 269.0M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 178.5K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.50 EPS Growth: N/A
52 Week Low/High: $0.62 - $2.54 Next Earning Date: 02-26-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A
P/E Ratio: N/A Index: N/A
Free Cash Flow: -54677000.0 FCF Growth: N/A

AI-Powered NAUT Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 72.08%
72.08%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: